Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma
@article{Jimenez2013CurrentAF, title={Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma}, author={C. Jimenez and E. Rohren and M. Habra and T. Rich and Paola Jim{\'e}nez and M. Ayala-Ramirez and E. Baudin}, journal={Current Oncology Reports}, year={2013}, volume={15}, pages={356-371} }
Pheochromocytomas (PHs) and sympathetic paragangliomas (SPGs) are rare neuroendocrine tumors. Approximately 17 % of these tumors are malignant, but because no molecular or histologic markers for malignancy exist, patients are often diagnosed with malignant PHs or SPGs after unresectable disease has formed. Patients with progressive metastatic tumors and overwhelming symptoms are currently treated with systemic chemotherapy and radiopharmaceutical agents such as metaiodobenzylguanidine. These… CONTINUE READING
Figures, Tables, and Topics from this paper
112 Citations
Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress
- Medicine
- Current Oncology Reports
- 2017
- 30
Management and outcome of metastatic pheochromocytomas/paragangliomas: an overview
- Medicine
- Journal of Endocrinological Investigation
- 2020
Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management
- Medicine
- Current opinion in endocrinology, diabetes, and obesity
- 2019
- 9
Pheochromocytoma and Paraganglioma: From Treatment to Follow-up
- Medicine
- Sisli Etfal Hastanesi tip bulteni
- 2020
- Highly Influenced
- PDF
Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer
- Medicine
- Front. Endocrinol.
- 2018
- 23
- PDF
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
- Medicine
- Current Treatment Options in Oncology
- 2020
- PDF
Malignant pheochromocytoma–paraganglioma: pathogenesis, TNM staging, and current clinical trials
- Medicine
- Current opinion in endocrinology, diabetes, and obesity
- 2017
- 43
Metastatic pheochromocytoma and paraganglioma: Management of endocrine manifestations, surgery and ablative procedures, and systemic therapies.
- Medicine
- Best practice & research. Clinical endocrinology & metabolism
- 2019
- 8
Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks
- Medicine
- Journal of clinical medicine
- 2020
- PDF
References
SHOWING 1-10 OF 105 REFERENCES
Metastatic pheochromocytoma and paraganglioma: focus on therapeutics.
- Medicine
- Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
- 2012
- 85
Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.
- Medicine
- Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
- 2009
- 20
Clinical review: Current treatment of malignant pheochromocytoma.
- Medicine
- The Journal of clinical endocrinology and metabolism
- 2007
- 162
- PDF
Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.
- Medicine
- The Journal of clinical endocrinology and metabolism
- 2009
- 135
Management and Treatment of Pheochromocytomas and Paragangliomas
- Medicine
- Annals of the New York Academy of Sciences
- 2006
- 73
- Highly Influential
Treatment of malignant pheochromocytoma.
- Medicine
- Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
- 2009
- 90
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.
- Medicine
- The Journal of clinical endocrinology and metabolism
- 2012
- 136
- PDF
The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
- Medicine
- Endocrine-related cancer
- 2007
- 257
- PDF
Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.
- Medicine
- Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
- 2012
- 57
Changing paradigms in the treatment of malignant pheochromocytoma.
- Medicine
- Cancer control : journal of the Moffitt Cancer Center
- 2011
- 47
- PDF